Ask AI about Teicos Pharma
Post your question publicly — other visitors, and whoever manages this page, can answer. It will be visible on this page.
Want to hear about this company again? Follow it and we’ll email you when a new review appears.
AI-generated from reviews on this page. Verify anything important with the company directly.
0 Reviews
Français
No reviews
Questions & Answers
No questions yet — be the first to ask.
Sign in to post
Your text is saved — you'll come right back to post.
Don't have an account? Create one
News & Press
No news yet. This is where the business shares its own updates and press.
Photos
No photos yet. Photos shared by reviewers will show up here.
About Teicos Pharma
Teicos Pharma's business is the production and sales of a new class of inhalable API (active pharmaceutical ingredient) powders for dry powder inhalers (DPI) based on a novel coating and encapsulation technology.
This technology remarkably improves the dosing and administration of the API from DPIs to the deep lung and eliminates the requirement for coarser carrier particles. The technology is versatile and can be applied to both local respiratory and systemic drugs.
Teicos Pharma's focus is on developing inhalable drug powders of customer specified pharmaceutical agents. Teicos Pharma develops and licenses new drug formulations and reformulations by establishing partnerships with leading drug companies and managing joint development projects.
Teicos Pharma is currently scaling its production for industrial use and is now seeking industrial partners to accelerate the uptake of the technology in the field of DPI inhalation therapy. The company has patents pending on the manufacturing process.
- Website
- teicospharma.com
- [email protected]
